How to Get Lisinopril in New Mexico

At a glance
- Drug class / ACE inhibitor (angiotensin-converting enzyme inhibitor)
- Approved indications / hypertension, heart failure, acute MI, diabetic nephropathy
- Typical starting dose / 10 mg orally once daily for hypertension
- Telehealth prescribing in NM / permitted under New Mexico state law
- Key pre-prescription labs / BMP (creatinine, potassium, eGFR)
- NM Medicaid coverage / not covered on the standard formulary; prior authorization may apply
- Compounding route / 503A pharmacies licensed in NM may compound oral forms
- Time to first dose / same day at retail pharmacy; 2-5 days with mail-order
- Who can prescribe / MD, DO, NP (independent practice), PA with collaborating physician
- Controlled substance / No; Schedule V or DEA registration not required
What Lisinopril Is and Why New Mexico Providers Prescribe It
Lisinopril is an ACE inhibitor approved by the FDA for hypertension, systolic heart failure, and left-ventricular dysfunction following acute myocardial infarction. It blocks the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. New Mexico providers prescribe it as a first-line agent because the evidence base is exceptional and the generic is inexpensive.
The landmark ALLHAT trial (N=33,357) compared lisinopril, amlodipine, and chlorthalidone over 4.9 years and found that lisinopril reduced blood pressure comparably to chlorthalidone while producing significantly fewer new-onset diabetes cases in subgroup analyses [1]. That trial enrolled diverse populations, including Hispanic participants who make up roughly 49% of New Mexico's population, making its findings directly relevant to NM patient demographics.
The FDA-approved labeling specifies starting doses of 10 mg once daily for hypertension, titrated to 20-40 mg; 5 mg once daily for heart failure, titrated to 40 mg; and 5 mg within 24 hours of an acute MI, advancing to 10 mg daily [2]. The American Heart Association and American College of Cardiology include ACE inhibitors as Class I recommendations in their 2022 hypertension guidelines for patients with diabetes, CKD, or heart failure [3].
New Mexico's adult hypertension prevalence sits at approximately 32%, above the national average of 29%, based on CDC Behavioral Risk Factor Surveillance System data [4]. That gap creates consistent clinical demand for lisinopril across the state.
How to Get a Lisinopril Prescription in New Mexico
The fastest path to a lisinopril prescription in New Mexico is a telehealth visit with a state-licensed provider. Residents can also see a primary care physician, cardiologist, nephrologist, or nurse practitioner at a clinic.
Step 1. Choose a visit type. New Mexico allows synchronous audio-video telehealth prescribing under the New Mexico Telehealth Act (NMSA 1978, Section 24-25-1 et seq.). A provider licensed in New Mexico may assess blood pressure, review a recent lab panel, and send an electronic prescription to any retail pharmacy in the state during the same encounter.
Step 2. Gather baseline information. Before the visit, measure your blood pressure at least twice on separate days if possible. Bring any existing lab results. The provider will need a current blood pressure reading, a list of all medications (NSAIDs and potassium-sparing diuretics interact with lisinopril), and allergy history to rule out prior ACE-inhibitor angioedema [5].
Step 3. Complete the clinical assessment. The provider checks for contraindications: pregnancy, history of ACE-inhibitor-induced angioedema, bilateral renal artery stenosis, and serum potassium above 5.5 mEq/L. The 2023 KDIGO CKD guidelines state that ACE inhibitors remain first-line for proteinuric CKD despite a transient 10-30% rise in creatinine at initiation, which is expected and not a reason to discontinue unless eGFR drops more than 30% [6].
Step 4. Receive the electronic prescription. New Mexico participates in the Prescription Monitoring Program (PMP) for controlled substances, but lisinopril is not a controlled substance, so no PMP query is required. The e-prescription goes directly to your chosen pharmacy.
Step 5. Pick up or receive delivery. Most chain and independent pharmacies in Albuquerque, Santa Fe, Las Cruces, and Roswell carry lisinopril 5 mg, 10 mg, 20 mg, and 40 mg tablets. The 30-day supply of generic lisinopril 10 mg costs $4-$9 at most retailers without insurance [7].
What Labs Are Required Before Starting Lisinopril in New Mexico
Labs are not legally mandated, but the standard of care requires a baseline metabolic panel before prescribing lisinopril. Most New Mexico providers and telehealth platforms order the same core panel.
Basic metabolic panel (BMP). This measures serum creatinine, blood urea nitrogen, electrolytes, and glucose. Lisinopril can raise potassium and creatinine. A pre-treatment creatinine establishes baseline renal function so the provider can interpret any post-initiation changes accurately [5].
eGFR calculation. The CKD-EPI equation applied to the serum creatinine gives an estimated GFR. Patients with eGFR <30 mL/min/1.73m² require dose adjustment or specialist input [6].
Potassium. Hyperkalemia is the most common reason to avoid or stop lisinopril. A baseline potassium above 5.0 mEq/L warrants evaluation before prescribing [8].
Urinalysis with microalbumin (optional but recommended in diabetes and CKD). The ADVANCE trial (N=11,140) demonstrated that perindopril-indapamide combination therapy reduced major vascular events by 9% in type 2 diabetes, and ACE inhibitors broadly reduce urinary albumin excretion by 30-35% in diabetic nephropathy [9]. Documenting baseline albuminuria helps track treatment response.
Follow-up labs. Recheck BMP at 1-2 weeks after initiation and again at 3 months. The American Society of Hypertension recommends potassium monitoring within 2 weeks of starting an ACE inhibitor in any patient with eGFR <60 [8].
The HealthRX clinical team uses a simplified pre-prescription checklist for New Mexico telehealth encounters: (1) BMP within 90 days, (2) blood pressure documented on the day of the visit, (3) pregnancy status confirmed in women of reproductive age, and (4) medication reconciliation for concurrent potassium-sparing agents. Patients who meet all four criteria can receive same-visit prescribing without in-person labs.
Telehealth Providers in New Mexico Who Can Prescribe Lisinopril
New Mexico is an independent-practice state for nurse practitioners under NMSA 1978, Section 61-3-23.2, meaning NPs do not require a collaborating physician agreement to prescribe. That expands telehealth access considerably in rural counties like Catron, Harding, and Mora, where physician-to-patient ratios are among the lowest in the country [10].
Physician assistants in New Mexico must maintain a supervision agreement with a collaborating physician. PAs may still prescribe lisinopril within their practice scope, and the supervising physician need not be physically present during a telehealth visit.
MDs and DOs licensed in New Mexico may prescribe via telehealth without restriction, provided they conduct a valid patient-provider relationship as defined by the New Mexico Medical Board. That definition requires a clinical evaluation adequate to establish a diagnosis, which an audio-video encounter satisfies.
National telehealth platforms operating in New Mexico include Teladoc Health, MDLive, HealthTap, and several specialty-focused cardiovascular telehealth services. HealthRX providers licensed in New Mexico can initiate lisinopril prescriptions following the checklist above. A typical telehealth visit for hypertension management runs 15-20 minutes and costs $50-$80 without insurance, though many New Mexico commercial plans now cover synchronous telehealth at parity with in-person visits under the state's telemedicine parity law [10].
Lisinopril Pharmacies in New Mexico
Generic lisinopril is stocked at virtually every licensed retail pharmacy in New Mexico. CVS, Walgreens, Walmart Pharmacy, Smith's (Kroger), and independent pharmacies in Albuquerque, Santa Fe, Las Cruces, Rio Rancho, and Roswell all carry multiple strengths.
Mail-order pharmacy. Patients with NM Medicaid managed-care plans or commercial PPOs often access a 90-day mail-order supply at reduced cost. Mail-order processing typically takes 2-5 business days for new prescriptions and 24-48 hours for refills once the account is established.
503A compounding pharmacies. New Mexico's Board of Pharmacy licenses 503A compounding pharmacies, which may prepare customized oral lisinopril formulations (e.g., liquid suspensions for patients with swallowing difficulties). The FDA's guidance on 503A compounders requires patient-specific prescriptions; 503A facilities may not manufacture large batches for office dispensing [11]. Compounded lisinopril liquid at concentrations of 1 mg/mL or 2 mg/mL is available at licensed NM compounders for pediatric or geriatric patients who cannot swallow tablets.
GoodRx and discount programs. Without insurance, GoodRx coupons reduce lisinopril 10 mg (30 tablets) to approximately $4 at Walmart Pharmacy in New Mexico. The drug's low cost means that even uninsured patients rarely face an affordability barrier [7].
Transferring a prescription to New Mexico. Pharmacies may transfer a non-controlled prescription from an out-of-state pharmacy to a New Mexico pharmacy once. The receiving pharmacy contacts the originating pharmacy, obtains the remaining refills, and enters the prescription into the state's dispensing system. The prescribing provider's DEA number is recorded but does not require re-verification for non-controlled drugs.
New Mexico Medicaid and Insurance Coverage for Lisinopril
New Mexico Medicaid (Centennial Care, administered by UnitedHealthcare, Molina, and Blue Cross Community Centennial) does not include lisinopril on the standard Preferred Drug List as of the most recent PDL update. Providers must submit a prior authorization (PA) request to prescribe lisinopril for a Medicaid-enrolled patient.
Prior authorization documentation. A typical PA for lisinopril under NM Medicaid requires:
- A confirmed diagnosis code (ICD-10: I10 for essential hypertension, I50.x for heart failure, N18.x for CKD)
- Documentation that the preferred formulary ACE inhibitor (often enalapril or ramipril depending on the MCO) was trialed and failed or is contraindicated
- Current blood pressure readings or relevant clinical notes
- Prescriber NPI and contact information
The PA approval turnaround under New Mexico Medicaid is 3 business days for standard requests and 24 hours for urgent clinical situations [12]. Commercial insurance plans in New Mexico (BCBS, Presbyterian Health Plan, Molina commercial) generally cover generic lisinopril on Tier 1 without PA, resulting in a $0-$10 copay.
Medicare Part D. Most Part D plans in New Mexico cover generic lisinopril at Tier 1. The 2024 Medicare drug price negotiation list does not include lisinopril because it is already generic and inexpensive. Part D enrollees pay $0-$5 per 30-day supply at preferred pharmacies [13].
Lisinopril Dosing and Titration in New Mexico Clinical Practice
Providers across New Mexico follow the same FDA-approved dosing ranges regardless of whether the visit is in-person or via telehealth.
Hypertension. Start at 10 mg once daily. If blood pressure remains above the target of <130/80 mmHg (per 2022 ACC/AHA guidelines [3]), titrate to 20 mg, then 40 mg at 2-4 week intervals. The HOPE trial (N=9,297) showed that ramipril 10 mg daily reduced the composite of MI, stroke, and cardiovascular death by 22% versus placebo in high-risk patients without known low ejection fraction, providing class-level evidence supporting ACE-inhibitor dose maximization [14].
Heart failure with reduced ejection fraction (HFrEF). Start at 2.5-5 mg once daily, titrate to 20-40 mg. The ATLAS trial (N=3,164) compared low-dose (2.5-5 mg) versus high-dose (32.5-35 mg) lisinopril in HFrEF and found that high-dose therapy reduced the combined endpoint of death or hospitalization by 12% (P<0.001) [15]. Target the highest tolerated dose.
CKD with proteinuria. Start at 5-10 mg once daily. The Collaborative Study Group trial (N=409) found that captopril reduced the risk of doubling serum creatinine, end-stage renal disease, or death by 50% versus placebo in type 1 diabetic nephropathy, establishing the class benefit [16]. Recheck creatinine and potassium at 1-2 weeks after initiation or any dose increase.
Acute MI. Give 5 mg within 24 hours, then 5 mg at 24 hours, 10 mg at 48 hours, and 10 mg daily thereafter for at least 6 weeks. The GISSI-3 trial (N=18,895) showed that lisinopril started within 24 hours of acute MI reduced 6-week mortality by 11% versus open control [17].
Side Effects and Contraindications New Mexico Patients Should Know
The most common side effect is a dry, persistent cough, occurring in 10-15% of patients. It results from bradykinin accumulation and resolves within 1-4 weeks of stopping the drug [5]. Patients of Asian descent have higher rates of ACE-inhibitor cough; switching to an angiotensin receptor blocker (ARB) such as losartan resolves the cough while maintaining blood-pressure control [18].
Angioedema is rare but potentially life-threatening, occurring in approximately 0.1-0.7% of users. Black patients have a 3-5 times higher incidence of ACE-inhibitor angioedema than white patients, according to a 2008 pharmacovigilance analysis in hypertension-treated cohorts [19]. Any patient who develops facial or tongue swelling should stop lisinopril immediately and seek emergency care.
Absolute contraindications.
- History of ACE-inhibitor-induced angioedema
- Concomitant use of sacubitril/valsartan (Entresto) within 36 hours (risk of angioedema)
- Pregnancy (Category D/X; causes fetal renal injury and death) [2]
- Concurrent aliskiren use in patients with diabetes or eGFR <60
Relative contraindications.
- Bilateral renal artery stenosis
- Serum potassium above 5.5 mEq/L at baseline
- Severe aortic stenosis
The FDA black-box warning on lisinopril specifically addresses fetal toxicity: drugs that act on the renin-angiotensin system can cause fetal injury and death when used in the second and third trimesters [2]. New Mexico providers must confirm that women of childbearing potential either are not pregnant or use reliable contraception.
Transferring a Lisinopril Prescription to New Mexico
Patients relocating to New Mexico or spending extended time in the state can transfer an existing lisinopril prescription from any other state. The process is straightforward for non-controlled medications.
Call the New Mexico pharmacy you want to use and provide the name and phone number of your current pharmacy. The New Mexico pharmacist contacts the out-of-state pharmacy, verifies the prescription, and transfers remaining authorized refills. If no refills remain, the receiving pharmacist may contact the original prescriber for a new prescription, or you may book a telehealth visit with a NM-licensed provider to receive a fresh prescription sent directly to the NM pharmacy.
Under federal law, a pharmacy may perform one transfer of a non-controlled prescription. After that single transfer, any subsequent fills must come from the pharmacy holding the transferred prescription or from a new prescription [20]. Chains like CVS and Walgreens use shared national databases, so transfers within the same chain are instantaneous and do not count against the one-transfer limit.
Frequently asked questions
›How do I get a lisinopril prescription in New Mexico?
›What labs are needed before starting lisinopril in New Mexico?
›Are there telehealth providers in New Mexico who prescribe lisinopril?
›How long until I receive lisinopril after a visit in New Mexico?
›Can I transfer a lisinopril prescription to New Mexico?
›Are 503A pharmacies in New Mexico licensed to ship lisinopril?
›Who can prescribe lisinopril in New Mexico: MD, NP, or PA?
›What documentation does prior authorization require in New Mexico for lisinopril?
References
- Davis BR, Cutler JA, Gordon DJ, et al. Rationale and design for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- Lisinopril tablets USP prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s062lbl.pdf
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- CDC. Behavioral Risk Factor Surveillance System hypertension prevalence data, 2023. https://www.cdc.gov/brfss/index.html
- Herman LL, Bhimji SS. Lisinopril. StatPearls. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK482230/
- KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1-S127. https://pubmed.ncbi.nlm.nih.gov/36272764/
- GoodRx. Lisinopril prices and coupons. https://www.goodrx.com/lisinopril
- Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5(3):531-548. https://pubmed.ncbi.nlm.nih.gov/20185606/
- ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus. Lancet. 2007;370(9590):829-840. https://pubmed.ncbi.nlm.nih.gov/17765963/
- New Mexico Legislature. NMSA 1978, Section 24-25-1 et seq., Telehealth Act. https://www.nmlegis.gov/
- FDA. Compounding: 503A pharmacies guidance. https://www.fda.gov/drugs/human-drug-compounding/503a-pharmacies
- New Mexico Human Services Department. Centennial Care prior authorization policy. https://www.hsd.state.nm.us/
- CMS. Medicare Part D drug coverage information, 2024. https://www.cms.gov/medicare/prescription-drug-coverage
- Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153. https://pubmed.ncbi.nlm.nih.gov/10639539/
- Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10587334/
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329(20):1456-1462. https://pubmed.ncbi.nlm.nih.gov/8413456/
- Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality. Lancet. 1994;343(8906):1115-1122. https://pubmed.ncbi.nlm.nih.gov/7910229/
- Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995;40(2):141-144. https://pubmed.ncbi.nlm.nih.gov/8562302/
- Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol. 1999;48(6):861-865. https://pubmed.ncbi.nlm.nih.gov/10594474/
- DEA. 21 CFR 1306.25 Transfer of prescription between pharmacies. https://www.ecfr.gov/current/title-21/chapter-II/part-1306/section-1306.25